Chronic low-grade inflammation in type 2 diabetes activates MAPK signaling and increases cytokines such as TNF-α, IL-6, and IL-8, which enhance thyroid cell proliferation, angiogenesis, and survival, favoring tumor development [176]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.